Advisory Committee on Immunization Practices (ACIP), 31490 [E8-12234]
Download as PDF
<![CDATA[
31490
Federal Register / Vol. 73, No. 106 / Monday, June 2, 2008 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
responses
per respondent
Number of
respondents
Average burden
per response
(in hours)
Total burden
(in hours)
Form name
Type of respondent
Invasive
Methicillin-resistant
Staphylococcus aureus ABCs Case Report
Form.
ABCs Invasive Pneumococcal Disease in
Children Case Report Form.
Neonatal Group B Streptococcal Disease
Prevention Tracking Form.
State Health Department.
10
609
20/60
2030
State Health Department.
State Health Department.
10
41
10/60
68
10
37
20/60
123
Total ....................................................
..................................
............................
............................
............................
4918
Dated: May 23, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E8–12192 Filed 5–30–08; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
Advisory Committee on Immunization
Practices (ACIP)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Centers for Disease Control and
Prevention
Public Health Service Act (PHS);
Delegation of Authority
jlentini on PROD1PC65 with NOTICES
Notice is hereby given that I have
delegated to the Director, National
Center for Preparedness, Detection and
Control of Infectious Diseases
(NCPDCID), and the Director, Division
of Global Migration and Quarantine
(DGMQ), NCPDCID, with authority to
redelegate, the authorities vested in the
Director, Centers for Disease Control
and Prevention, under sections 361(a),
(b), (c), (d), and 362, Title III, of the PHS
Act (Control of Communicable Diseases,
42 U.S.C. 264 and 265. The authority
delegated under 361(a) does not include
the authority to promulgate regulations.
This delegation became effective upon
date of signature. In addition, I have
affirmed and ratified any actions taken
by the Director, NCPDCID, the Director,
DGMQ, NCPDCID, or their subordinates
which involved the exercise of
authorities delegated herein prior to the
effective date of the delegation.
Dated: May 20, 2008.
Julie Louise Gerberding,
Director, Centers for Disease Control and
Prevention.
[FR Doc. E8–12176 Filed 5–30–08; 8:45 am]
BILLING CODE 4160–18–M
VerDate Aug<31>2005
19:06 May 30, 2008
Jkt 214001
Centers for Disease Control and
Prevention
Times and Dates: 8 a.m.–6 p.m., June 25,
2008. 8 a.m.–5 p.m., June 26, 2008.
Place: CDC, Tom Harkin Global
Communications Center, 1600 Clifton Road,
NE., Building 19, Kent ‘‘Oz’’ Nelson
Auditorium, Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The committee is charged with
advising the Director, CDC, on the
appropriate uses of immunizing agents. In
addition, under 42 U.S.C. 1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for administration
to vaccine-eligible children through the
Vaccines for Children (VFC) program, along
with schedules regarding the appropriate
periodicity, dosage, and contraindications
applicable to the vaccines.
Matters to be Discussed: The agenda will
include discussions on Rotavirus Vaccines;
Combination Vaccines; MMRV Vaccine;
Human Papillomavirus Vaccines;
Pneumococcal Vaccines; Measles Outbreaks
in the United States (2008); Adult
Immunization Schedule; Anthrax Vaccine;
Influenza Vaccines; Rabies Vaccine and
Biologicals; Vaccine Supply; and
Immunization Safety Update. There may be
VFC voting on the Rotavirus, Combination
and Human Papillomavirus Vaccines.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Antonette Hill, Immunization Services
Division, National Center for Immunization
and Respiratory Diseases, CDC, 1600 Clifton
Road, NE., (E–05), Atlanta, Georgia 30333,
Telephone (404) 639–8836, Fax (404) 639–
8905.
The Director, Management Analysis and
Services Office, has been delegated the
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the CDC and ATSDR.
Dated: May 27, 2008.
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–12234 Filed 5–30–08; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Food Safety Research; Investigations
Focused on Promoting the Safety of
Produce
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA-Center for Food
Safety and Applied Nutrition (CFSAN))
is announcing the availability of
approximately $1.0 million in research
funds for fiscal year (FY) 2008. It is
anticipated that individual grants will
receive a total of $250,000 to $500,000
to cover both direct and indirect costs.
These funds will be used to support
research efforts to advance the safe
transportation and preparation of
produce and to help reduce the
incidence of foodborne illness that may
be associated with fresh produce
consumption. The award will provide
18 months of support. There will be no
additional years of noncompetitive
continuation support. A copy of the full
text of this announcement will be
posted in Grants.gov and on FDA’s
Center for Food Safety and Applied
Nutrition Web site at https://
www.cfsan.fda.gov/list.html.
Key Dates: Receipt Date: Applications
are due within 90 days after the
publication of the funding opportunity
in the Federal Register.
E:\FR\FM\02JNN1.SGM
02JNN1
]]>Agencies
[Federal Register Volume 73, Number 106 (Monday, June 2, 2008)]
[Notices]
[Page 31490]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-12234]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Times and Dates: 8 a.m.-6 p.m., June 25, 2008. 8 a.m.-5 p.m.,
June 26, 2008.
Place: CDC, Tom Harkin Global Communications Center, 1600
Clifton Road, NE., Building 19, Kent ``Oz'' Nelson Auditorium,
Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: The committee is charged with advising the Director,
CDC, on the appropriate uses of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is mandated to establish and
periodically review and, as appropriate, revise the list of vaccines
for administration to vaccine-eligible children through the Vaccines
for Children (VFC) program, along with schedules regarding the
appropriate periodicity, dosage, and contraindications applicable to
the vaccines.
Matters to be Discussed: The agenda will include discussions on
Rotavirus Vaccines; Combination Vaccines; MMRV Vaccine; Human
Papillomavirus Vaccines; Pneumococcal Vaccines; Measles Outbreaks in
the United States (2008); Adult Immunization Schedule; Anthrax
Vaccine; Influenza Vaccines; Rabies Vaccine and Biologicals; Vaccine
Supply; and Immunization Safety Update. There may be VFC voting on
the Rotavirus, Combination and Human Papillomavirus Vaccines.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Antonette Hill,
Immunization Services Division, National Center for Immunization and
Respiratory Diseases, CDC, 1600 Clifton Road, NE., (E-05), Atlanta,
Georgia 30333, Telephone (404) 639-8836, Fax (404) 639-8905.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both the CDC and ATSDR.
Dated: May 27, 2008.
Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-12234 Filed 5-30-08; 8:45 am]
BILLING CODE 4160-18-P
